MUVALAPLIN

UNII:	HSU2KY4EFK
Type:	INGREDIENT SUBSTANCE
Formula:	C₄₂H₅₄N₄O₆
Preferred Substance Name:	MUVALAPLIN
InChIKey:	BRLGERLDHZRETI-BGBFCPIGSA-N
GSRS Full Record:	HSU2KY4EFK i

2565656-70-2
(1<sup>3</sup>R,2S,10S,11<sup>3</sup>R)-6-[(3-{(2S)-2-carboxy-2-[(3R)-pyrrolidin-3-yl]ethyl}phenyl)methyl]-6-aza-1,11(3)-dipyrrolidina-4,8(1,3)-dibenzenaundecaphane-2,10-dicarboxylic acid
(2S)-3-[3-[[bis[[3-[(2S)-2-carboxy-2-[(3R)-pyrrolidin-3-yl]ethyl]phenyl]methyl]amino]methyl]phenyl]-2-[(3R)-pyrrolidin-3-yl]propanoic acid
(2S)-3-[3-[[bis[[3-[(2S)-2-carboxy-2-[(3R)-pyrrolidin-3-yl]ethyl]phenyl]methyl]amino]phenyl]-2-[(3R)-pyrrolidin-3-yl]propanoic acid
(2S,2'S,2''S)-3,3',3''-((nitrilotris(methylene))tris(benzene-3,1-diyl))tris(2-((R)-pyrrolidin-3-yl)propanoic acid)
3-Pyrrolidineacetic acid, α,α',α''- [nitrilotris(methylene-3,1-phenylenemethylene)]tris-, (αS,α'S,α''S,3R,3'R,3''R)-
LY-3473329
LY3473329
MUVALAPLIN [USAN]
Muvalaplin
Muvalaplin [WHO-DD]
muvalaplin [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MUVALAPLIN

Synonyms and Mappings

Resources